Reliance Global Group, Inc. (EZRA)
NASDAQ: EZRA · Real-Time Price · USD
0.1620
-0.0080 (-4.71%)
May 11, 2026, 9:48 AM EDT - Market open
Reliance Global Group Employees
Reliance Global Group had 40 employees as of December 31, 2025. The number of employees decreased by 24 or -37.50% compared to the previous year.
Employees
40
Change (1Y)
-24
Growth (1Y)
-37.50%
Revenue / Employee
$300,538
Profits / Employee
-$168,051
Market Cap
3.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 40 | -24 | -37.50% |
| Dec 31, 2024 | 64 | -3 | -4.48% |
| Dec 31, 2023 | 67 | -11 | -14.10% |
| Dec 31, 2022 | 78 | - | - |
| Sep 30, 2020 | 43 | - | - |
| Jun 30, 2020 | 39 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Crawford & Company | 9,943 |
| Crawford & Company | 9,943 |
| AIFU Inc. | 4,707 |
| SelectQuote | 4,269 |
| eHealth | 1,665 |
| Goosehead Insurance | 1,600 |
| Huize Holding | 853 |
| GoHealth | 850 |
EZRA News
- 3 days ago - Reliance Global Group Earnings Call Transcript: Q1 2026 - Transcripts
- 3 days ago - Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments - GlobeNewsWire
- 4 days ago - Reliance Global Group Transcript: AGM 2026 - Transcripts
- 4 days ago - Reliance Global Group Schedules First Quarter 2026 Financial Results and Business Update Conference Call - GlobeNewsWire
- 6 days ago - Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment - GlobeNewsWire
- 7 days ago - Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA's Biotech Division - GlobeNewsWire
- 13 days ago - Reliance Global increases ownership in Enquantum to 29% - TheFly
- 13 days ago - Reliance Global Group Increases Ownership in Enquantum to 29% Following Achievement of Defined Technical and Commercial Milestones - GlobeNewsWire